Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 12, 2024
Second opinion and self-efficacy in German skin cancer patients
Henner Stege, Sara Schneider, Andrea Forschner, et al.
Medical Oncology (Northwood, London, England)
|
April 20, 2016
Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma
Carmen Loquai, Dagmar Dechent, Marlene Garzarolli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2008
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)
K Spieth, R Kaufmann, R Dummer, et al.
Deutsche Medizinische Wochenschrift (1946)
|
October 21, 2016
[Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension]
K M Olsson, M Halank, B Egenlauf, et al.
Medicine
|
November 19, 2016
Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy
Katharina C Kaehler, Christine Blome, Andrea Forschner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
F Egberts, R Gutzmer, S Ugurel, et al.
Science (New York, N.Y.)
|
September 12, 2015
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M Van Allen, Diana Miao, Bastian Schilling, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2019
Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases
Ricarda Rauschenberg, Johannes Bruns, Julia Brütting, et al.
Journal for Immunotherapy of Cancer
|
May 7, 2020
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG
Sarah Knispel, Andreas Stang, Lisa Zimmer, et al.
Plos One
|
January 24, 2013
The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
Caroline J Voskens, Simone M Goldinger, Carmen Loquai, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 12, 2024
Second opinion and self-efficacy in German skin cancer patients
Henner Stege, Sara Schneider, Andrea Forschner, et al.
Medical Oncology (Northwood, London, England)
|
April 20, 2016
Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma
Carmen Loquai, Dagmar Dechent, Marlene Garzarolli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2008
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)
K Spieth, R Kaufmann, R Dummer, et al.
Deutsche Medizinische Wochenschrift (1946)
|
October 21, 2016
[Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension]
K M Olsson, M Halank, B Egenlauf, et al.
Medicine
|
November 19, 2016
Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy
Katharina C Kaehler, Christine Blome, Andrea Forschner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
F Egberts, R Gutzmer, S Ugurel, et al.
Science (New York, N.Y.)
|
September 12, 2015
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M Van Allen, Diana Miao, Bastian Schilling, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2019
Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases
Ricarda Rauschenberg, Johannes Bruns, Julia Brütting, et al.
Journal for Immunotherapy of Cancer
|
May 7, 2020
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG
Sarah Knispel, Andreas Stang, Lisa Zimmer, et al.
Plos One
|
January 24, 2013
The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
Caroline J Voskens, Simone M Goldinger, Carmen Loquai, et al.
Page
of 3